⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3717151 | 1.00 | — | — | |
| SCHEMBL3650166 | 0.83 | — | — | |
| SCHEMBL910214 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL27369352 | 0.72 | — | — | |
| Hydrogen Sulfide SCHEMBL5678861 | 0.72 | — | — | |
| SCHEMBL21449776 | 0.71 | — | — | |
| SCHEMBL13123342 | 0.69 | — | — | |
| SCHEMBL19242570 | 0.69 | ALDH1A1 (0.30) | — | |
| SCHEMBL4660826 | 0.67 | — | — | |
| SCHEMBL21150626 | 0.67 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200599-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEARING LOSS | Merz Pharma GmbH & Co. KGaA (DE) | 2010-06-30 | — | — | EP | disclosed |
| EP-2162124-A1 | NERAMEXANE FOR THE TREATMENT OF NYSTAGMUS | Merz Pharma GmbH & Co. KGaA (DE) | 2010-03-17 | — | — | EP | disclosed |
| WO-2009033650-A1 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEARING LOSS | MERZ PHARMA GMBH & CO.KGAA (DE) | 2009-03-19 | — | — | WO | disclosed |
| WO-2008148564-A1 | NERAMEXANE FOR THE TREATMENT OF NYSTAGMUS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2008-12-11 | — | — | WO | disclosed |